Syndax Pharmaceuticals Inc Stock Agreements

Description of Capital Stock (Filed With SEC on February 27, 2024)

Stock Purchase Agreement by and between the Company and Incyte Corporation, dated as of September 24, 2021 (Filed With SEC on November 15, 2021)

Description of Capital Stock (Filed With SEC on March 5, 2020)

SYNDAX PHARMACEUTICALS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 4, 2016)

SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on January 4, 2016)

AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)

SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on January 4, 2016)

SyndaxPharmaceuticals, Inc. Common Stock ($0.0001 Par Value) EQUITYUNDERWRITING AGREEMENT (Filed With SEC on May 16, 2014)

SYNDAX PHARMACEUTICALS, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on March 27, 2014)

SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN NOTICE OF STOCK OPTION GRANT (Filed With SEC on March 27, 2014)

AMENDMENT TO SYNDAXPHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on March 27, 2014)

SYNDAX PHARMACEUTICALS, INC. 2007 STOCK PLAN (Filed With SEC on March 27, 2014)